NHS

Showing 15 posts of 1107 posts found.

ABPI image

Pharma underwrites medicines bill with £207 million

June 8, 2015
Manufacturing and Production, Sales and Marketing ABPI, NHS, PPRS, ahsn, brett wells

The Department of Health and the ABPI have confirmed a payment of £207 million from pharma to underwrite growth of …

NICE image

NICE: people should be more involved in medical decisions

June 2, 2015
Sales and Marketing NHS, NICE, medicines, optimisation

Around 15 million people in England now have at least one long-term condition, but figures suggest that as many as …

NICE image

NICE sets out office for market access plans

May 28, 2015
Sales and Marketing ABPI, EMA, NHS, NICE, eams, market access

The UK healthcare watchdog NICE is to set up a new office for market access to advise pharma companies on …

Jevtana image

Sanofi prostate cancer drug to remain on CDF

May 26, 2015
Sales and Marketing CDF, Cancer, NHS, Sanofi, list, prostate

Sanofi has reached an agreement with NHS England to reinstate its prostate cancer drug Jevtana on the Cancer Drugs Fund. …

Bayer image

Bayer wins Cancer Drugs Fund appeal

May 22, 2015
Sales and Marketing Bayer, CDF, Cancer Drugs Fund, Eisai, NHS, lilly

Bayer is the only company to win its appeal to NHS England in the latest round of Cancer Drugs Fund …

NHS online starting to take shape

May 20, 2015
Medical Communications, Sales and Marketing HSCIC, NHS, brett wells, nhs online

In England over 55 million patients can now order repeat prescriptions, book GP appointments and access their medical records online …

NHS image

Cameron restates £8 billion NHS funding plans

May 18, 2015
Sales and Marketing BMA, Cameron, NHS, UK

UK prime minister David Cameron has committed to extra funding for the NHS in his first major speech following the …

UK doctors urged to curb overtreatment

May 13, 2015
Sales and Marketing Academy of Medical Royal Colleges, BMJ, NHS, uk doctors

The UK’s body of medical colleges has launched a new campaign to warn of the dangers of over-treating patients with …

NHS image

Scottish Medicines Consortium approves seven drugs

May 12, 2015
Sales and Marketing NHS, SMC, Scottish Medicines Consortium

The Scottish Medicines Consortium has accepted seven new medicines and indications for use on the NHS in Scotland. Two of …

NHS image

NHS ‘close to breaking point’

April 30, 2015
Medical Communications, Sales and Marketing BMJ, Godlee, Kings Fund, NHS, king's fund

England’s NHS is ‘stretched close to breaking point’ and the next five years are likely to be the most challenging …

Pharma accused of hiding behind regulation and undermining NICE

April 29, 2015
Medical Communications, Sales and Marketing NHS, NICE, Royal Society of Medicine, UK, brett wells, health, pharma

University of York health economists have argued that pharma regulation is not evidence-based, lacks accountability and undermines NICE. Writing in …

arzerra image

Trial results back NICE decision on Novartis cancer drug

April 15, 2015
Sales and Marketing Arzerra, Cancer, NHS, NICE, chemo, chlorambucil, fludarabine, leukaemia, ofatumumab

Treatment with Arzerra improves survival in people with chronic lymphocytic leukaemia (CLL) according to study results that back NICE’s decision …

Phone image

E-clinical: the rise of new health technologies

April 13, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, NHS, apps, digital, eHealth, eyeforpharma, kelsey, pharma, wearables

In the UK the NHS is generally considered to be traditionally resistant to new technology, but it has been forced …

Over one billion drugs dispensed in England in 2014, NHS report shows

April 9, 2015
Sales and Marketing HSCIC, NHS, drug cost, net ingredient cost, prescribing, prescription cost analysis, prescriptions

Patients in England collected over 1.1 billion prescription items in 2014, according to NHS figures. Statistics from the Health and …

Lucentis image

Novartis accused of Lucentis ‘campaign’ against Avastin

April 2, 2015
Sales and Marketing Lucentis, NHS, Novartis, avastin, bevacizumab, ranibizumab, wet AMD

Novartis “embarked on a campaign to undermine and divert attention” from a cheap drug for vision loss and maintain the …

The Gateway to Local Adoption Series

Latest content